When the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease (AD) was subjected to a secondary inflammatory challenge with interleukin-1β (IL-1β), primed astrocytes developed exaggerated chemokine responses [21]. This evidence concerns the gene IL1B and Alzheimer disease.